There has been a great deal of recent progress in our understanding of the transcriptional control of adipogenesis. Current data suggest that fat cell differentiation involves an interplay between the CaEBP family of transcription factors and PPARg g. The thermogenic program of brown fat cells may also include a contribution from a new coactivator, PGC-1. Recent data suggests that this coactivator is responsible for activation of thermogenesis and oxidative metabolism in both brown fat and muscle. The PGC-1 dependent program includes both mitochondrial biogenesis and tissue-speci®c expression of uncoupling proteins.
Introduction
The regulation of energy balance involves an interplay between several distinct tissues and physiological systems. Differences between energy intake (feeding) and energy dissipation will be re¯ected in changes in body composition. When food intake chronically exceeds energy dissipation, obesity may develop, most of this energy is stored in the form of triglycerides located primarily in adipose tissue. It is now appreciated that fat cells are much more than a passive receptacle for fat deposition; fat cells produce and secrete a large and growing number of signaling molecules such as TNFa, leptin and plasminogen activator inhibitor (PAI)-1. 1 Because fat cells are active players in systemic energy balance there has been an increased interest in understanding the molecules that control the differentiation and function of this cell type.
Most studies of adipogenesis have relied on cultured cell lines that can differentiate into white or brown fat cells. These cell lines usually require hormone or drug stimulation to differentiate; the belief that they represent an authentic view of the differentiation process in vivo is based primarily on the fact that the program of genes expressed in these cells are relatively representative of adipose tissues. Thus, 3T3-L1 and 3T3-F442A are widely used to study white fat differentiation. HIB1B and HB2 cells are used to study the differentiation of brown adipose cells.
Transcription control of adipogenesis Ð PPARg g
It is now clear that fat cell differentiation is controlled by an interplay between the CaEBP basic-leucine zipper family of transcription factors and PPARg, a member of the nuclear receptor gene family.
PPARg was cloned as a component of a transcriptional complex that binds to and regulates the fatspeci®c enhancer derived from the aP2 gene. 2 It was independently cloned by other groups screening for new members of the PPAR subgroup of nuclear receptors. 3 ± 5 PPARg is expressed predominantly in adipose tissues, but is also expressed at high levels in the colon and in many other tissues at lower levels. This receptor functions as an obligate heterodimer with RXR, and binds to DNA sequences called DR-1 elements. PPARg was shown to bind to and activate the adipose-speci®c enhancers from the aP2 and PEPCK genes. A role in adipogenesis per se was shown by ectopic expression and activation in ®bro-blastic cells. Ligand activation of PPARg was suf®-cient to give a robust adipogenic differentiation, as evidenced by lipid accumulation, morphological changes, expression of many genes characteristic of fat, and the cessation of cell growth. 6 In addition to the cell culture models, ligand activation of PPARg stimulates adipogenesis in vivo. This was shown in obese animals by giving them the PPARg ligand troglitazone (see below). 7 In addition to this`gain of function' data, three groups have recently described a requirement for PPARg to get adipogenesis in vivo. An adipogenic response to PPARg activators in human was shown by treating patients with poorly differentiated liposarcoma, a malignancy of the adipose lineage, with the PPARg ligand troglitazone. A profound differentiation response in these tumors was observed, 8 presenting the ®rst example of experimental induction of differentiation of solid tumors. While this raises hopes for the use of PPARg in the`differentiation therapy' of liposarcoma and other malignancies, it clearly illustrates the ability of PPARg to control fat differentiation in intact humans.
PPARg g ligands
A key observation was the determination that PPARg is the functioning receptor for the anti-diabetic thiazolidinedione (TZD) drugs. 9, 10 Two of these drugs, developed by traditional medical chemistry approaches, are available in the US for the treatment of type 2 diabetes mellitus Ð troglitazone (Rezulin Using competition binding assays with radioactive TZDs, a number of natural ligands have been identi®ed, including 15 deoxyD 12,14 PG J2, 9 and linoleic acid. 10, 11 However, it is important to note that these natural ligands, all derivatives of fatty acids, bind with a K d of 2 ± 50 mM, a much lower af®nity that is typically shown by genuine endogenous ligands for nuclear receptors. Hence, the search for a high-af®nitỳ endogenous' ligand for PPARg continues.
CaEBPs and a transcriptional cascade
The CaEBPs also play a critical role in adipogenesis. 12`K nock-out' mice for CaEBPa and for the combination of CaEBPb and d have greatly reduced fat. Most genes expressed in fat cells selectively have binding sites for members of the CaEBP family, as well as PPAR binding sites. Interestingly, CaEBP sites are often located in or near the proximal promoters, while PPAR sites tend to be in upstream enhancers.
Data developed over the last few years suggests a major role for the CaEBPs in the regulation of PPARg. CaEBPb and d expression appears to turn on the expression of PPARg. 13 Activation of PPARg can then turn on CaEBPa, as well as the full program of adipogenic gene expression. 14 CaEBPa can synergize with PPARg in promoting the adipogenic program, but it is also required to maintain the expression of PPARg. Thus, it is clear that the stability of the transcriptional program of adipogenesis depends upon the cross-regulation between PPARg and CaEBPa. 14 Work with CaEBPa-de®cient ®broblasts has illustrated another striking function of this factor-regulation of the program of insulin sensitivity. These ®broblasts were converted into fat cells using ectopic expression of PPARg. Even in the absence of CaEBPa, most fat cell genes examined were expressed quite normally, including aP2 and Glut4.
However, these cells had no insulin-stimulated glucose transport at all, unlike wild-type ®broblasts converted to fat cells in an identical fashion. Moreover, an examination of components of the insulin signaling system indicated that the differentiationlinked induction of the insulin receptor and IRS-1 seen in wild-type cells was completely absent in mutant cells. 14, 15 Thus, the role of CaEBPa in adipogenesis is at least 3-fold: maintenance of PPARg expression, synergy with PPARg in differentiation and regulation of insulin-dependent glucose transport. Presumably, loss of these functions (and perhaps others) accounts for the reduction in fat observed in CaEBPa-de®cient mice.
White versus brown fat Ð role of PGC-1
While white fat cells function primarily to store energy, brown adipose cells dissipate energy in the form of heat. This is done primarily through the increased number of mitochondria and the presence of an uncoupling protein (UCP-1) in these mitochondria. There has been much interest in this cell type, which is quite abundant in rodents but less obvious in humans, because an increase in number andaor activity of these cells could lead to novel anti-obesity therapies. At present, very little is known about the molecular basis of brown vs white differentiation. Brown cells, like white, express PPARg and the CaEBPs. Indeed, activation of PPARg in cultured brown fat precursor cells stimulates differentiation of these cells. One potential hint of an answer to this problem is the recent isolation of a PPARginteracting protein, PGC-1, that is expressed in brown but not white fat. 16 PGC-1 interacts with and coactivates PPARg and the whole family of nuclear receptors. PGC-1 is expressed in several tissues, but is cold inducible in brown fat and skeletal muscle. These are believed to be two key tissues in adaptive thermogenesis. Ectopic expression of PGC-1 in white fat or muscle cells induces a broad program of thermogenesis, including increased respiration, mitochondrial biogenesis and increased expression of uncoupling proteins. 17 UCP-1 is induced in white fat cells while UCP-2 is induced in muscle cells. 17 Given that the actions of PGC-1 closely mirror the key biological functions that distinguish brown from white fat, it is reasonable to hypothesize that this factor is responsible for cells being determined as brown or white cells.
However, whether PGC-1 promotes the thermogenic program in brown cells determined through other molecules, or is the brown fat determinant factor is not clear. Ultimately, this must be tested through experiments in transgenic mice.
Most recently, the mechanisms by which PGC-1 can induce mitochondrial biogenesis have been examined. PGC-1 induces the activity of two key factors, NRF-1 and NRF-2, that bind to and regulate the promoters of many nuclear genes that encode mitochondrial proteins. Furthermore, PGC-1 binds to and coactivates NRF-1, a key player in the regulation of mitochondrial transcription Factor A (Mt TFA), a protein that translocates into the mitochondrial and initiation DNA replication and transcription. 17 
